Review
doi: 10.1053/j.gastro.2014.09.002.
Epub 2014 Sep 16.
American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome
Affiliations
- PMID: 25224525
- DOI: 10.1053/j.gastro.2014.09.002
Item in Clipboard
Review
American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome
Gastroenterology.
2014 Nov.
No abstract available
Similar articles
-
American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.Gastroenterology. 2014 Nov;147(5):1146-8. doi: 10.1053/j.gastro.2014.09.001. Epub 2014 Sep 16. Gastroenterology. 2014. PMID: 25224526 No abstract available.
-
The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence.J Gastrointestin Liver Dis. 2014 Dec;23(4):431-5. doi: 10.15403/jgld.2014.1121.234.mibs. J Gastrointestin Liver Dis. 2014. PMID: 25532003 Review. No abstract available.
-
How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5 Suppl 1):21-6. doi: 10.1586/17474124.2013.820046. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23859757 Review.
-
Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.Med Lett Drugs Ther. 2008 Jul 14;50(1290):53-4. Med Lett Drugs Ther. 2008. PMID: 18617872 No abstract available.
-
End points in irritable bowel syndrome.Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):293-5. doi: 10.1586/egh.11.13. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21651345 No abstract available.
Cited by
-
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015. PLoS One. 2015. PMID: 26222318 Free PMC article. Clinical Trial.
-
Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence.Curr Gastroenterol Rep. 2016 Aug;18(8):41. doi: 10.1007/s11894-016-0517-x. Curr Gastroenterol Rep. 2016. PMID: 27372289 Review.
-
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32308371 Free PMC article. Review.
-
The associations between modifiable risk factors and constipation: a comprehensive mendelian randomization study.BMC Gastroenterol. 2024 Oct 17;24(1):370. doi: 10.1186/s12876-024-03384-8. BMC Gastroenterol. 2024. PMID: 39420266 Free PMC article.
-
Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility.J Neurogastroenterol Motil. 2018 Jul 30;24(3):479-489. doi: 10.5056/jnm17093. J Neurogastroenterol Motil. 2018. PMID: 29715711 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
